COVID-19
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according to preliminary results from a pre-clinical trial.
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according to preliminary results from a pre-clinical trial.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
